Researchers find a potential signature of cognitive function in people living with HIV

UH researchers have identified a unique epigenetic footprint in specific types of immune cells from blood that can identify individuals with HIV that have a range of impairments in cognitive function.

 Read their article:http://manoa.hawaii.edu/news/article.php?aId=8131

Comments

Post a Comment

Popular posts from this blog

First New Drug for Liver Cancer in a Decade: Regorafenib

The US Food and Drug Administration (FDA) has expanded the indication for regorafenib ( Stivarga , Bayer) to now include treatment for patients with hepatocellular carcinoma (HCC) who have previously been treated with the drug sorafenib ( Nexavar , Bayer). Expansion of regorafenib's indication marks the first FDA-approved treatment for a liver cancer in almost a decade! Medscape article: http://www.medscape.com/viewarticle/879216?src=soc_fb_170427_mscpedt_news_onc_livercancer
Read more